🇺🇸 FDA
Patent

US 10167270

Substituted quinazoline compounds and uses thereof for modulating glucocerebrosidase activity

granted A61KA61K38/47A61P

Quick answer

US patent 10167270 (Substituted quinazoline compounds and uses thereof for modulating glucocerebrosidase activity) held by Northwestern University expires Mon Dec 27 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Northwestern University
Grant date
Tue Jan 01 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 27 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K38/47, A61P, A61P25/16, A61P25/28